We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
226
DELISTED
SpringWorks Therapeutics
SWTX
| $18M | 0.03% |
+428,644
| New | +$15.3M |
|
|
ONEM
227
DELISTED
1Life Healthcare
ONEM
| $17.8M | 0.03% |
490,966
+37,945
| +8% | +$1.07M |
|
228
Stoneridge
SRI
$213M
| $17.8M | 0.03% |
860,839
+74,886
| +10% | +$1.4M |
|
229
Casey's General Stores
CASY
$30.9B
| $17.7M | 0.03% |
118,063
+9,131
| +8% | +$1.38M |
|
|
IMMU
230
DELISTED
Immunomedics Inc
IMMU
| $17.6M | 0.03% |
497,816
-105,961
| -18% | -$3.1M |
|
231
Floor & Decor
FND
$6.68B
| $17.6M | 0.03% |
304,705
+59,147
| +24% | +$2.7M |
|
232
Sphere Entertainment
SPHR
$5.73B
| $17.5M | 0.03% |
+233,636
| New | +$18M |
|
233
Pegasystems
PEGA
$5.38B
| $17.5M | 0.03% |
345,718
+26,680
| +8% | +$1.16M |
|
|
AERI
234
DELISTED
Aerie Pharmaceuticals
AERI
| $17.4M | 0.03% |
+1,181,778
| New | +$17.5M |
|
235
American Water Works
AWK
$26.9B
| $17.3M | 0.03% |
134,655
-1,763
| -1% | -$220K |
|
236
Teleflex
TFX
$5.98B
| $17.1M | 0.03% |
46,938
-7,086
| -13% | -$2.45M |
|
237
Globus Medical
GMED
$11.2B
| $17M | 0.03% |
356,805
+27,710
| +8% | +$1.34M |
|
238
Morningstar
MORN
$7.53B
| $17M | 0.03% |
120,523
+9,337
| +8% | +$1.32M |
|
239
Sun Communities
SUI
$14.7B
| $17M | 0.03% |
124,962
+3,839
| +3% | +$510K |
|
|
CCXI
240
DELISTED
ChemoCentryx, Inc.
CCXI
| $16.8M | 0.03% |
+292,119
| New | +$15.9M |
|
241
Champion Homes
SKY
$5.14B
| $16.8M | 0.03% |
690,094
-4,973
| -0.7% | -$104K |
|
242
Bio-Techne
TECH
$11.3B
| $16.6M | 0.03% |
251,860
+67,476
| +37% | +$4.04M |
|
243
Chegg
CHGG
$102M
| $16.6M | 0.03% |
246,493
+18,877
| +8% | +$1.01M |
|
244
Vistra
VST
$47.4B
| $16.5M | 0.03% |
887,466
-306,425
| -26% | -$5.78M |
|
245
Ziff Davis
ZD
$1.98B
| $16.5M | 0.03% |
299,400
+23,229
| +8% | +$1.52M |
|
246
Semtech
SMTC
$13B
| $16.4M | 0.03% |
314,527
+24,389
| +8% | +$1.14M |
|
247
Kemper
KMPR
$1.68B
| $16.3M | 0.03% |
224,699
+17,436
| +8% | +$1.17M |
|
|
AXON
248
Axon Enterprise
AXON
$46.4B
| $16.1M | 0.03% |
+163,871
| New | +$13.2M |
|
|
LSXMK
249
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $15.9M | 0.03% |
594,818
-1,406
| -0.2% | -$36.2K |
|
250
El Paso Energy Capital Trust I
EP.PRC
$223M
| $15.4M | 0.02% |
1,016,415
+2,324
| +0.2% | +$107K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.